Isomab Ltd
PrivateLast Round
Seed
Feb 20, 2024
Total Funding Raised
$9.4M
Momentum Score
50 /100
Company Overview
Isomab Ltd is a biotechnology company that develops isoform-specific antibodies for the treatment of life-limiting diseases with peripheral ischemia.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isomab Ltd Comps
Public and private peers based on sector, stage, and business model.
Isomab Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 20, 2024 |
Isomab Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Seed |
| Mercia Ventures | Seed |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 221% MoM.
- Apr 5, 2026
Monthly visitors increased 48% MoM.
Isomab Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isomab Ltd's valuation, stock price, and market status.
